|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 07, 2016 ) Global Solid Tumors Drugs Market 2016-2020 Size and Share Published in 2016-06-24 Available for US$ 2500 at Researchmoz.us
Description
The rising prevalence of various cancers, which has led to innovations and technological advancements, drives the development of new immunotherapy drugs that are more effective than the available drugs to treat solid tumors.
Solid tumors are an abnormal mass of tissue that do not contain cysts or liquid areas. These may be malignant (cancerous) or benign (not cancerous). They affect bones, organs, and muscles. Based on the type of the cells, solid tumors can be carcinomas, sarcomas, and lymphomas.
Technavios analysts forecast the global solid tumors drugs market to grow at a CAGR of 8.6% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global solid tumors drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded drugs, generics, and biosimilars used to treat solid tumors. It also considers the revenues to be generated from the sales of drugs that are anticipated to be launched into the market along with the decline in revenues from the patent expiries of the branded drugs during the forecast period.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Download Sample of this Report at: http://www.researchmoz.us/enquiry.php?type=S&repid=745940
Technavio's report, Global Solid Tumors Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
F. Hoffmann-La Roche
Novartis
Celgene
Johnson & Johnson
Pfizer
BMS
Other prominent vendors
AbbVie
AbGenomics
ADC Therapeutics
Advantagene
Agensys
Almac Group
Ambrx
Argos Therapeutics
Array BioPharma
Astellas Pharma
AstraZeneca
Bayer
Biogen
Biotech Pharmaceutical
Boehringer Ingelheim
Boston Biomedical
Celldex Therapeutics
Chugai Pharmaceutical
Cold Genesys
CTI BioPharma
Daiichi Sankyo
DNAtrix
Ds-Pharma
Eleison Pharmaceuticals
Eli Lilly
Endo Pharmaceuticals
Formation Biologics
Fortress Biotech
Genmab
GSK
Immatics Biotechnologies
Immunogen
Immunomedics
Intas Pharmaceuticals
Kairos Therapeutics
Kyowa Hakko Kirin
MedImmune
Merck
Mersana Therapeutics
Morphotek
Neovii Biotech
NewLink Genetics
Northwest Biotherapeutics
Novartis
OncoMed Pharmaceuticals
Oxford Biotherapeutics
Peregrine Pharmaceuticals
Polaris Pharmaceuticals
Sanofi
Seattle Genetics
Spectrum Pharmaceuticals
Stemcentrx
Synthon Biopharmaceuticals
TG Therapeutics
XBiotech
Market driver
Exposure to risk factors
For a full, detailed list, view our report
Market challenge
Patent expiration of top-selling drugs
For a full, detailed list, view our report
Market trend
Emergence of targeted and combination therapies
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
Make an Enquiry: http://www.researchmoz.us/enquiry.php?type=E&repid=745940
Table of Content
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Assumptions
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
Markers used for diagnosis of solid tumors
PART 05: Cost analysis
PART 06: Pipeline portfolio
Anticipated number of products with single and multiple indications by 2020
Browse All Pharmaceutical Market Research Reports at: http://www.researchmoz.us/pharmaceutical-market-reports-38.html
About ResearchMoz
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.
Contact Us:
ResearchMoz
Mr. Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
sales@researchmoz.us <||>rnhttp://www.researchmoz.us/
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
